Ablative fractional resurfacing in topical drug delivery: an update and outlook
- PMID: 23294061
- DOI: 10.1111/dsu.12111
Ablative fractional resurfacing in topical drug delivery: an update and outlook
Abstract
Background: The effective delivery of therapeutic molecules to varied targets in the skin and elsewhere has been an area of ongoing research and development.
Objective: To review the structure of the skin with an emphasis on topical drug delivery and to present the rationale for the use of ablative and nonablative fractional resurfacing in assisted drug delivery.
Methods and materials: Review of the currently available scientific literature on laser-assisted drug delivery.
Results: A number of strategies can be employed to enhance topical drug delivery. Ablative fractional resurfacing (AFR) has been demonstrated to be effective in enhancing drug delivery. Further studies are needed to assess the use of nonablative fractional resurfacing in assisted drug delivery.
Conclusion: AFR-assisted drug delivery is a promising tool for the future of dermatology. We expect to see a number of agents to be paired with AFR for enhanced drug delivery. Further investigation is necessary to evaluate appropriate drug specific channel density and depth parameters. Factors that must be considered include the physicochemical properties of the drug, the target tissue, skin wounding, and cost when evaluating the drugs and conditions that will most benefit from this promising new drug delivery system.
© 2012 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.
Similar articles
-
Laser systems for ablative fractional resurfacing.Expert Rev Med Devices. 2011 Jan;8(1):67-83. doi: 10.1586/erd.10.74. Expert Rev Med Devices. 2011. PMID: 21158542 Review.
-
Evolution of laser skin resurfacing: from scanning to fractional technology.Dermatol Surg. 2014 Nov;40(11):1163-72. doi: 10.1097/01.DSS.0000452648.22012.a0. Dermatol Surg. 2014. PMID: 25285818 Review.
-
Topical delivery of triamcinolone via skin pretreated with ablative radiofrequency: a new method in hypertrophic scar treatment.Int J Dermatol. 2013 Mar;52(3):367-70. doi: 10.1111/j.1365-4632.2012.05704.x. Int J Dermatol. 2013. PMID: 23414164
-
Fractional laser skin resurfacing.J Drugs Dermatol. 2012 Nov;11(11):1274-87. J Drugs Dermatol. 2012. PMID: 23135075
-
The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing.J Am Acad Dermatol. 2008 May;58(5):719-37; quiz 738-40. doi: 10.1016/j.jaad.2008.01.003. J Am Acad Dermatol. 2008. PMID: 18423256
Cited by
-
Semiconductor diode laser device adjuvanting intradermal vaccine.Vaccine. 2017 Apr 25;35(18):2404-2412. doi: 10.1016/j.vaccine.2017.03.036. Epub 2017 Mar 30. Vaccine. 2017. PMID: 28365253 Free PMC article.
-
Laser-assisted topical corticosteroid delivery for the treatment of keloids.Lasers Med Sci. 2017 Apr;32(3):601-608. doi: 10.1007/s10103-017-2154-5. Epub 2017 Jan 26. Lasers Med Sci. 2017. PMID: 28124198
-
Comparative study of fractional CO2 laser and fractional CO2 laser-assisted drug delivery of topical steroid and topical vitamin C in macular amyloidosis.Lasers Med Sci. 2018 May;33(4):909-916. doi: 10.1007/s10103-018-2457-1. Epub 2018 Feb 26. Lasers Med Sci. 2018. PMID: 29480422
-
Fractional Carbon Dioxide (CO2) Laser Alone Versus Fractional CO2 Laser Combined With Triamcinolone Acetonide or Trichloroacetic Acid in Keloid Treatment: A Comparative Clinical and Radiological Study.Dermatol Pract Concept. 2022 Apr 1;12(2):e2022072. doi: 10.5826/dpc.1202a72. eCollection 2022 May. Dermatol Pract Concept. 2022. PMID: 35646428 Free PMC article.
-
Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines.Expert Opin Drug Deliv. 2013 Jun;10(6):761-73. doi: 10.1517/17425247.2013.773970. Epub 2013 Feb 21. Expert Opin Drug Deliv. 2013. PMID: 23425032 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
